Longmont, Colo.-based Acertara has been awarded U.S. patent #9,513,237 for its probe testing system, Active-Z and U.S patent #9,525,257 for its electrical leakage omni-connector, Accept. Active-Z is a portable, point-of-care test device for ultrasound probes that enables field personnel and sonographers to verify the proper functioning of their probe.
By measuring the complex impedance of a probe the Active-Z user can quickly triage if a probe can be repaired or needs to be replaced.
The Omni-connector, Accept is part of an transducer electrical leakage suite. Accept’s design will connect to virtually every ultrasound manufacturer and probe model, eliminating the need for hospitals to purchase multiple adapters. Further, Accept was introduced to assist hospitals with accreditation under the Intersocietal Accreditation Commission’s requirements to test probes for electrical leakage before every case.
Commenting on the patents, G. Wayne Moore, President and CEO of Acertara, says: “Our approach has always been to develop novel test devices that position our customers to provide safe and effective care in an environment that controls costs. The Active-Z and Accept patents are examples of that approach that will enable better patient outcomes.”
Acertara is an independent International Organization for Standardization/International Electrotechnical Commission (IEC) 17025:2005 accredited medical ultrasound acoustic measurement, testing, and calibration laboratory, and an ISO13485:200-certified probe repair and new product development facility.